Dompé Fluifort 2,7g / 10ml Syrup In 12 Sachets Of 10ml

Dompé FLUIFORT Syrup in single dose

What is it for?

Fluifort is a ready-to-use syrup based on carbocysteine salt of lysine for cough and colds and expectorants, excluding associations with cough sedatives, mucolytics.

How does it work?

This syrup acts as a mucolytic, fluidifying in acute and chronic respiratory diseases, thanks to its active ingredients it is effective in counteracting these problems.

Active principles

A 10 ml sachet of 27% syrup contains the following active ingredients: carbocysteine lysine salt monohydrate equal to 2.7 g of carbocysteine lysine salt. Excipients: methyl para – hydroxybenzoate, propyl para – hydroxybenzoate, sorbitol. For the full list of excipients, see section 6.1.

Excipients

Sorbitol (70% solution); xylitol; ammonium glycyrrhizinate; carmellose sodium; glycerol; cherry flavor; methyl para-hydroxybenzoate; propyl para-hydroxybenzoate; purified water.

Therapeutic indications

Mucolytic, fluidifying in acute and chronic respiratory diseases.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Gastroduodenal ulcer. Pregnancy and breastfeeding. The drug is contraindicated in pediatric patients under 11 years of age.

How to use

In a very simple and quick way, 1 sachet a day is enough. Fluifort 2.7 g / 10 ml syrup, thanks to its innovative packaging, ensures precision in dosage, hygiene, practicality and ease of intake and is particularly suitable for diseases in the acute phase for which short-term treatment is required. In consideration of the pharmacokinetic characteristics, the recommended posology can be maintained even in patients with renal and hepatic insufficiency. Duration of treatment: carbocysteine lysine salt monohydrate can also be used for prolonged periods, in this case it is advisable to follow the doctor's advice.

Warnings and Precautions

There are no known phenomena of addiction or dependence. The medicine contains methyl para-hydroxybenzoate and propyl para-hydroxybenzoate, which are known to cause hives. In general, para-hydroxybenzoates can cause delayed reactions, such as contact dermatitis and rarely immediate reactions with manifestation of urticaria and bronchospasm. The medicine contains sorbitol, patients with rare hereditary problems of fructose intolerance should not take this medicine. Fluifort 2.7 g / 10 ml syrup does not affect low-calorie or controlled diets and can also be administered to diabetic patients. Fluifort 2.7 g / 10 ml syrup does not contain aspartame; therefore it can be administered to patients with phenylketonuria. Fluifort 2.7 g / 10 ml syrup does not contain gluten; therefore it can be administered to patients with celiac disease. Open the sachet following the dotted line and ingest its contents.

Interactions

In controlled clinical trials, no interactions were found with the most common drugs used in the treatment of upper and lower respiratory tract diseases, nor with food and with laboratory tests.

Side effects

The undesirable effects that may occur with Fluifort, classified by system organ (SOC), are the following: Skin, subcutaneous tissue disorders: skin rash, urticaria, erythema, rash, bullous rash / erythema, pruritus, angioedema, dermatitis. Gastrointestinal disorders: abdominal pain, nausea, vomiting, diarrhea. Nervous system disorders: dizziness. Respiratory, thoracic and mediastinal disorders: dyspnoea Vascular disorders: redness.

Pregnancy and breastfeeding

Although the active substance is neither teratogenic nor mutagenic and has not shown adverse effects on reproductive function in animals, Fluifort should not be administered during pregnancy (see 4.3). Since no data are available regarding the passage of carbocysteine lysine salt monohydrate into breast milk, use during lactation is contraindicated (see 4.3).

Format

Fluifort syrup is sold in packs of 12 single-dose sachets of 10ml. It is also sold in 6 or 10 sachets format.